Targeted inhibition of human breast cancer cell lines selected as model systems of ERBB2-positive/EGFR high breast cancer [RPPA-Longterm-HCC1954-SKBR3]
Ontology highlight
ABSTRACT: EGFR-inhibition is required for targeted therapies of ERBB2-positive/EGFR high breast cancer. Approximately 30% of human ERBB2-positive breast tumors also express EGFR.
ORGANISM(S): Homo sapiens
PROVIDER: GSE50108 | GEO | 2014/08/13
SECONDARY ACCESSION(S): PRJNA216095
REPOSITORIES: GEO
ACCESS DATA